TrialClinical cancer research : an official journal of the American Association for Cancer Research2019

MAVERICC, a Randomized, Biomarker-stratified, Phase II Study of mFOLFOX6-Bevacizumab versus FOLFIRI-Bevacizumab as First-line Chemotherapy in Metastatic Colorectal Cancer.

Aparna R Parikh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.